Navigation Links
Quest Diagnostics Initiates CEO Succession Process

MADISON, N.J., Oct. 25, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX) today announced that its Board of Directors has begun the process of identifying a successor to Surya N. Mohapatra, Ph.D., President, Chairman and Chief Executive Officer.  The Board of Directors has formed a search committee, engaged a leading executive recruitment firm and will consider both external and internal candidates.

Dr. Mohapatra has agreed to continue to serve as Chairman and CEO for up to six months to ensure a smooth transition.

Daniel C. Stanzione, Ph.D., Lead Independent Director, said: "Under Surya's leadership Quest Diagnostics has established itself as a patient-focused healthcare company. It has built an engine for growth in esoteric and gene-based testing, focused on the critically important areas of cancer, cardiovascular disease, infectious disease and neurological disorders. The company has a solid foundation for the future, and will continue to focus on delivering strong operating performance and increased shareholder value while we progress through this transition. The company and the healthcare industry have benefited greatly from Surya's leadership and vision."

"I am proud of the Quest Diagnostics team of 42,000 colleagues and what they have accomplished," said Dr. Mohapatra. "In the 12 years I've been with the company, it has been gratifying to see revenues grow five-fold to $7.5 billion and earnings grow at a compound annual rate of 21%. Today, we perform testing for 150 million patients each year, serve over half of America's physicians and hospitals, and have been recognized on Fortune Magazine's list of the World's Most Admired Companies.

"Our passion for patients, drive for growth and commitment to people have made us the world leader in diagnostic testing, information and services. With unmatched assets in science and innovation, information technology and access and distribution now in place, the Board and I agreed that this is the right time to transition to new leadership. It has been truly an honor and privilege to serve as Chairman of the Board and CEO of this great company. "

Dr. Mohapatra joined the company as Chief Operating Officer in February, 1999 and became President later that year.  He was appointed CEO in May, 2004 and was named Chairman of the Board in December, 2004.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at:

CONTACT: For Quest Diagnostics: Kathleen Valentine (Investors), +1-973-520-2900, or Gary Samuels (Media), +1-973-520-2800

SOURCE Quest Diagnostics Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Diamonds, silver and the quest for single photons
2. Maryland Stem Cell Research Commission Issues 2012 Requests for Applications (RFAs)
3. Questcor Pharmaceuticals to Present at Upcoming Investor Conferences in September
4. HDS International Comments on Front-end Carbon Sequestration Technologies
5. Quest Diagnostics and Genomic Vision Form Strategic Collaboration to Develop Genome-based Laboratory Tests
6. Clinical Genomics Extends Strategic Alliance for Colorectal Cancer Testing Development with Quest Diagnostics
7. GEN point of view article questions reported costs of drug R&D
8. Questcor Pharmaceuticals to Present at the Jefferies Global Healthcare Conference on June 9, 2011
9. FDA Requests Input on Development of User Fee Program for Biosimilar and Interchangeable Biological Products
10. GenomeQuest to Lead Biomarker World Congress Panel on Applying Whole Genome Sequencing to Developing Companion Diagnostics
11. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for Pharmaceutical Engineering ... premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference took place ... the largest number of attendees in more than a decade. , “The ...
(Date:11/24/2015)... N.C. , Nov. 24, 2015  Clintrax Global, Inc., a ... North Carolina , today announced that the company has set ... represented a 391% quarter on quarter growth posted for Q3 of ... and Mexico , with the establishment ... in December 2015. --> United Kingdom ...
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions leader SAP and ... to develop and pitch their BIG ideas to improve health and wellness in their ... votes to win the title of SAP's Teen Innovator, an all-expenses paid trip to ...
(Date:11/24/2015)... -- SHPG ) announced today that Jeff Poulton ... th Annual Healthcare Conference in New York City ... EST (1:30 p.m. GMT). --> SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
Breaking Biology Technology:
(Date:10/27/2015)... SAN JOSE, Calif. , Oct. 27, 2015 /PRNewswire/ ... human interface solutions, today announced that Google has adopted ... family of touch controller solutions to power its newest ... Nexus 6P by Huawei. --> ... ecosystem partners like Google to provide strategic collaboration in ...
(Date:10/26/2015)... Oct. 26, 2015  Delta ID Inc., a company ... mobile and PC devices, announced its ActiveIRIS® technology powers ... NX F-02H launched by NTT DOCOMO, INC in ... the second smartphone to include iris recognition technology, after ... NX F-04G in May 2015, world,s first smartphone to ...
(Date:10/22/2015)... (NASDAQ: AWRE ), a leading supplier of biometrics software and ... 30, 2015.  --> --> ... decrease of 33% compared to $6.0 million in the same quarter ... $2.2 million, or $0.10 per diluted share, which compared to $2.6 ... year ago.  --> --> ...
Breaking Biology News(10 mins):